AMY WHITSA: Open Payments
NPI 1487322921 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 14 payments from 9 companies in 2025. Trend: 2023 $492 · 2024 $202 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $135 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| BETA BIONICS, INC. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: EVENITY, HORIZANT, CRYSVITA, JARDIANCE, BEXSERO, CAPLYTA, iLet Bionic Pancreas, Kerendia.
Industry payments across OR — which companies pay providers there.
